We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Expands Access to Investigational Drugs, Clarifies Charges
FDA Expands Access to Investigational Drugs, Clarifies Charges
August 14, 2009
The FDA has revised its investigational new drug (IND) rules to expand access to such drugs for patients who are seriously ill or have life-threatening conditions and lack other treatment options, and to permit charging for the drugs in studies or expanded-access programs.